As the COVID-19 pandemic continues to spread in the U.S. and abroad, public companies are grappling with the ramifications (real or potential) of a senior executive(s) contracting the virus.
Together with senior management, boards of directors should be actively reviewing their emergency preparedness plans, including their emergency succession plans for key executives. Boards also need to proactively address the possibility that one or more directors become sick, including by reviewing the board’s contingency plans to ensure the board will be able to continue to perform its duties.
Click here, to continue reading on the Cleary M&A and Corporate Governance Watch blog.